author-photo

J. R. Park

University of Washington

14

Papers

238

Citations

Citation Trend

Filter By

Papers (12) Sort By

Journal Conference Others

Abstract LB-300: Natural antibodies to non-human glycans Neu5Gc and alpha-gal correlate with outcome of high-risk neuroblastoma patients treated with dinutuximab on COG ANBL0032 and ANBL0931

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Identification of novel, rare markers for poor survival in high-risk neuroblastoma patients by merging and reanalysing existing datasets

2017
Show All
- Source
- Cite
- Save
Citations (0)
Reply to J. Stenman et al

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A phase I study of zoledronic acid (ZA) and low-dose cyclophosphamide (CTX) in children with recurrent/refractory neuroblastoma (NB): A New Approaches to Neuroblastoma Therapy (NANT) study

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children’s Oncology Group study

2015 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (78)
SIOP‐PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low‐ and middle‐income settings

2015 Pediatric Blood & Cancer
Show All
- Source
- Cite
- Save
Citations (42)
Low-dose chemotherapy and rituximab for posttransplant lymphoproliferative disease (PTLD)

2012 American Journal of Transplantation
Show All
- Source
- Cite
- Save
Citations (0)
Low-Dose Chemotherapy and Rituximab for Posttransplant Lymphoproliferative Disease (PTLD): A Children's Oncology Group Report: Rituximab Plus Chemotherapy in Pediatric PTLD

2012 American Journal of Transplantation
Show All
- Source
- Cite
- Save
Citations (24)
A randomized phase III trial of myeloablative autologous peripheral blood stem cell (PBSC) transplant (ASCT) for high-risk neuroblastoma (HR-NB) employing immunomagnetic purged (P) versus unpurged (UP) PBSC: A Children’s Oncology Group study

2008 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (15)
Response and toxicity to a dose-intensive multi-agent chemotherapy induction regimen for high risk neuroblastoma (HR-NB): A Children's Oncology Group (COG A3973) study

2007 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (24)